DBT

Phase-I clinical trial has been completed in age groups ranging from 18 to 60 years

The output of Covaxin drug substance will be three-to-four million a month, and from December, will increase to 10 million a month

CDSCO puts in place system to fast track processing of application for clinical trial and approval for COVID-19 vaccines

The information was given today by Mansukh Mandaviya, Union Minister of Chemicals and Fertilizers, in a written reply in the Lok…

COVID-19 provides opportunity to work on strategic research outcomes which are specifically India-centric, said the Union Minister

Few weeks ago, inter-ministerial teams had visited the sites of two main vaccine manufacturers in India to get their inputs on how…

The theme for the event is “Transforming Lives” with the tag line “Biosciences to Bio-economy.”

The CEPI laboratory will be a great addition to the ability of THSTI to enhance the quality of services towards making vaccine and…

It will identify up to 25 best health tech solutions from startups/ SMEs and provide pilot testbeds in collaboration with State…

She said the vaccines that are being developed indigenously are on different platforms and each has its own benefits and…